TWO-YEAR SUSTAINED EFFICACY OF A NOVEL, POLYMER-FREE SIROLIMUS ELUTING STENT: LATE RESULTS OF THE VESTASYNC II TRIAL

Background Nonpolymeric drug-eluting stents (DES) have arisen as an attractive alternative to minimize local inflammatory reactions and potentially reduce the adverse events observed following the 1st generation of DES with thick, durable polymers.

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E212-E212
Main Authors: de Ribamar Costa, Jos&eacute, Abizaid, Alexandre, Costa, Ricardo, Almeida, Breno, Feres, Fausto, Perin, Marco, Tanajura, Luiz Fernando, Sousa, Amanda, Sousa, J Eduardo
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Hydroxyapatite
Internal Medicine
Stents
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Nonpolymeric drug-eluting stents (DES) have arisen as an attractive alternative to minimize local inflammatory reactions and potentially reduce the adverse events observed following the 1st generation of DES with thick, durable polymers.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(12)60213-7